Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Cited by (1,053)

Items 101–200 of 1,053

1. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
   Connie B. Newman, David Preiss, Jonathan A. Tobert, Terry A. Jacobson, Robert Lee Page II, Larry B. Goldstein, Clifford C. Chin, Lisa R. Tannock, Michael J. Miller, Geetha Raghuveer et al. · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
2. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation
   Vlachopoulos, Charalambos, Xaplanteris, Panagiotis, Aboyans, Victor, Brodmann, Marianne, Cífková, Renata, Cosentino, Francesco, De Carlo, Marco, Gallino, Augusto, Landmesser, Ulf, Laurent, Stéphane et al. · 2015 · Atherosclerosis
3. Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
   Batya B. Davidovici, Naveed A. Sattar, Jörg C. Prinz, L. Puig, Paul Emery, Jonathan N. Barker, Peter van de Kerkhof, Mona Ståhle, Frank Oliver Nestle, Giampiero Girolomoni et al. · 2010 · Journal of Investigative Dermatology
4. ESC/EAS Guidelines for the management of dyslipidaemias
   Catapano, Alberico L., Reiner, Željko, De Backer, Guy, Graham, Ian, Taskinen, Marja-Riitta, Wiklund, Olov, Agewall, Stefan, Alegria, Eduardo, Chapman, M. John, Durrington, Paul et al. · 2011 · Atherosclerosis
5. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
   Mega, Jessica L, Stitziel, Nathan O, Smith, J Gustav, Chasman, Daniel I, Caulfield, Mark J, Devlin, James J, Nordio, Francesco, Hyde, Craig L, Cannon, Christopher P, Sacks, Frank M et al. · 2015 · The Lancet
6. The pharmacology of statins
   Cesare Riccardo Sirtori · 2014 · Pharmacological Research
7. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation
   Varbo, Anette, Benn, Marianne, Tybjærg-Hansen, Anne, Nordestgaard, Børge G. · 2013 · Circulation
8. Targeting inflammation in the treatment of type 2 diabetes: time to start
   Donath, Marc Y. · 2014 · Nature Reviews Drug Discovery
9. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
   Paul M. Ridker, Deepak L. Bhatt, Aruna D. Pradhan, Robert J. Glynn, Jean G. MacFadyen, Steven E. Nissen · 2023 · The Lancet
10. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
    Swerdlow, Daniel I, Preiss, David, Kuchenbaecker, Karoline B, Holmes, Michael V, Engmann, Jorgen E L, Shah, Tina, Sofat, Reecha, Stender, Stefan, Johnson, Paul C D, Scott, Robert A et al. · 2015 · The Lancet
11. Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
    Golomb, Beatrice A, Evans, Marcella A · 2008 · American Journal of Cardiovascular Drugs
12. Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
    Peter Libby, Andrew H. Lichtman, Göran K. Hansson · 2013 · Immunity
13. Biosynthesis of isoprenoids via the non-mevalonate pathway
    Wolfgang Eisenreich, Adelbert Bacher, D. Arigoni, Felix Rohdich · 2004 · Cellular and Molecular Life Sciences
14. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
    Amarenco, Pierre, Labreuche, Julien · 2009 · The Lancet Neurology
15. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
    Matthew J. Feinstein, Priscilla Y. Hsue, Laura A. Benjamin, Gerald S. Bloomfield, Judith S. Currier, Matthew S. Freiberg, Steven Kyle Grinspoon, Jules Levin, Chris Todd Longenecker, Wendy S. Post · 2019 · Circulation
16. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
    Jared R. Mayers, Chen Hsuan Wu, Clary B. Clish, Peter Kraft, Margaret E. Torrence, Brian P. Fiske, Chen Yuan, Ying Bao, Mary K. Townsend, Shelley S. Tworoger et al. · 2014 · Nature Medicine
17. Stroke injury, cognitive impairment and vascular dementia
    Kalaria, Raj N., Akinyemi, Rufus, Ihara, Masafumi · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
18. The contributory role of gut microbiota in cardiovascular disease
    Tang, W.H. Wilson, Hazen, Stanley L. · 2014 · Journal of Clinical Investigation
19. American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
    Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger, Guillermo E. Umpierrez, Robert S. Zimmerman, Timothy Silleck Bailey, Lawrence Blonde, George A. Bray, A. Jay Cohen, Samuel E. Dagogo-Jack et al. · 2015 · Endocrine Practice
20. Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
    Patricia Marchio, Sol Guerra‐Ojeda, José María Vila, Martı́n Aldasoro, Víctor M. Víctor, María Dolores Mauricio · 2019 · Oxidative Medicine and Cellular Longevity
21. Interleukin-1 Beta as a Target for Atherosclerosis Therapy
    Peter Libby · 2017 · Journal of the American College of Cardiology
22. <i>Bacteroides vulgatus</i> and <i>Bacteroides dorei</i> Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis
    Yoshida, Naofumi, Emoto, Takuo, Yamashita, Tomoya, Watanabe, Hikaru, Hayashi, Tomohiro, Tabata, Tokiko, Hoshi, Namiko, Hatano, Naoya, Ozawa, Genki, Sasaki, Naoto et al. · 2018 · Circulation
23. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
    Wilbert S. Aronow, Jerome L. Fleg, Carl J. Pepine, Nancy T. Artinian, George L. Bakris, Alan S. Brown, Keith C. Ferdinand, Mary Ann Forciea, William H. Frishman, Cheryl S. Jaigobin et al. · 2011 · Circulation
24. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants
    Ahmed M. Alaa, Thomas R Bolton, Emanuele Di Angelantonio, James H F Rudd, Mihaela van der Schaar · 2019 · PLoS ONE
25. Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
    Quynh Nhu Dinh, Grant Raymond Drummond, Christopher Graeme Sobey, Sophocles Chrissobolis · 2014 · BioMed Research International
26. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
    US Preventive Services Task Force, Kirsten B. Bibbins-Domingo, David C. Grossman, Susan J. Curry, Karina W. Davidson, John W. Epling, Francisco García, Matthew W. Gillman, Alex R. Kemper, Alex H. Krist et al. · 2016 · JAMA
27. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.
    Charalambos V. Vlachopoulos, Panagiotis Xaplanteris, Victor Aboyans, Marianne Brodmann, Renata Cífková, Francesco Cosentino, Marco De Carlo, Augusto Gallino, Ulf Landmesser, Stéphane Laurent et al. · 2015 · HAL
28. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
    Elena Myasoedova, Cynthia S. Crowson, Hilal Maradit Kremers, Veronique Lee Roger, Patrick D. Fitz‐Gibbon, Terry M. Therneau, Sherine E. Gabriel · 2011 · Annals of the Rheumatic Diseases
29. Endothelial Cell Metabolism
    Guy Eelen, Pauline de Zeeuw, Lucas Treps, Ulrike Harjes, Brian W. Wong, Peter Carmeliet · 2017 · Physiological Reviews
30. Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
    Boekholdt, S. Matthijs, Hovingh, G. Kees, Mora, Samia, Arsenault, Benoit J., Amarenco, Pierre, Pedersen, Terje R., LaRosa, John C., Waters, David D., DeMicco, David A., Simes, R. John et al. · 2014 · Journal of the American College of Cardiology
31. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
    Natarajan, Pradeep, Young, Robin, Stitziel, Nathan O., Padmanabhan, Sandosh, Baber, Usman, Mehran, Roxana, Sartori, Samantha, Fuster, Valentin, Reilly, Dermot F., Butterworth, Adam et al. · 2017 · Circulation
32. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    Lloyd-Jones, Donald M., Morris, Pamela B., Ballantyne, Christie M., Birtcher, Kim K., Covington, Ashleigh M., DePalma, Sondra M., Minissian, Margo B., Orringer, Carl E., Smith, Sidney C., Waring, Ashley Arana et al. · 2022 · Journal of the American College of Cardiology
33. Statins for Prevention of Cardiovascular Disease in Adults
    Roger Chou, Tracy Dana, Ian Blazina, Monica Daeges, Thomas L. Jeanne · 2016 · JAMA
34. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank
    Patel, Aniruddh P., Wang, Minxian, Pirruccello, James P., Ellinor, Patrick T., Ng, Kenney, Kathiresan, Sekar, Khera, Amit V. · 2021 · Arteriosclerosis, Thrombosis, and Vascular Biology
35. Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
    Qian Zhou, James K. Liao · 2010 · Circulation Journal
36. Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
    Willeit, Peter, Ridker, Paul M, Nestel, Paul J, Simes, John, Tonkin, Andrew M, Pedersen, Terje R, Schwartz, Gregory G, Olsson, Anders G, Colhoun, Helen M, Kronenberg, Florian et al. · 2018 · The Lancet
37. Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
    Enrica Golia, Giuseppe Limongelli, Francesco Natale, Fabio Fimiani, Valeria Maddaloni, Ivana Pariggiano, Renatomaria Bianchi, Mario Crisci, Ludovica D’Acierno, Roberto Campos Giordano et al. · 2014 · Current Atherosclerosis Reports
38. A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians
    Heejung Shim, Daniel I. Chasman, Joshua D. Smith, Samia Mora, Paul M. Ridker, Deborah A. Nickerson, Ronald M. Krauss, Matthew Stephens · 2015 · PLoS ONE
39. American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
    Handelsman, Yehuda, Bloomgarden, Zachary T., Grunberger, George, Umpierrez, Guillermo, Zimmerman, Robert S., Bailey, Timothy S., Blonde, Lawrence, Bray, George A., Cohen, A. Jay, Dagogo-Jack, Samuel et al. · 2015 · Endocrine Practice
40. Atherosclerosis
    Kouji Kobiyama, Klaus F. Ley · 2018 · Circulation Research
41. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
    David Buckley, Rongwei F. Fu, Michele Freeman, Kevin R. Rogers, Mark Helfand · 2009 · Annals of Internal Medicine
42. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
    Kristine Højgaard Allin, Børge Grønne Nordestgaard · 2011 · Critical Reviews in Clinical Laboratory Sciences
43. Anti-inflammatory therapies for cardiovascular disease
    Paul M. Ridker, Thomas Felix Lüscher · 2014 · European Heart Journal
44. Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
    Olle Melander · 2009 · JAMA
45. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis
    Navarese, Eliano P., Robinson, Jennifer G., Kowalewski, Mariusz, Kolodziejczak, Michalina, Andreotti, Felicita, Bliden, Kevin, Tantry, Udaya, Kubica, Jacek, Raggi, Paolo, Gurbel, Paul A. · 2018 · JAMA
46. Inflammation, Immunity, and Infection in Atherothrombosis
    Libby, Peter, Loscalzo, Joseph, Ridker, Paul M, Farkouh, Michael E., Hsue, Priscilla Y., Fuster, Valentin, Hasan, Ahmed A., Amar, Salomon · 2018 · Journal of the American College of Cardiology
47. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
    Tsuyoshi Shirai, Rafal Robert Nazarewicz, Barbara B. Wallis, Rolando E. Yanes, Ryu Watanabe, Marc L. Hilhorst, Lü Tian, David Glenn Harrison, John C. Giacomini, Themistocles L. Assimes et al. · 2016 · The Journal of Experimental Medicine
48. Effects of Statins on Coronary Atherosclerotic Plaques
    Sang‐Eun Lee, Hyuk‐Jae Chang, Ji Min Sung, Hyung‐Bok Park, Ran Heo, Asim Rizvi, Fay Yu-Huei Lin, Amit Kumar, Martin Hadamitzky, Yong Jin Kim et al. · 2018 · JACC. Cardiovascular imaging
49. CD14++CD16+ Monocytes Independently Predict Cardiovascular Events
    Kyrill Sebastian Rogacev, Bodo Cremers, Adam M. Zawada, Sarah Seiler, Nadine Binder, Philipp Ege, Gunnar Große-Dunker, I Armtn Heisel, Florian Hornof, Jana Jeken et al. · 2012 · Journal of the American College of Cardiology
50. Sudden Cardiac Death Caused by Coronary Heart Disease
    Robert J. Myerburg, Juhani M. Junttila · 2012 · Circulation
51. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
    Paul S. Jellinger, Donald Angehr Smith, Adi Mehta, Om P. Ganda, Yehuda Handelsman, Helena W. Rodbard, Mark D. Shepherd, John A. Seibel · 2012 · Endocrine Practice
52. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
    Borén, Jan, Williams, Kevin Jon · 2016 · Current Opinion in Lipidology
53. Exercise protects the cardiovascular system: effects beyond traditional risk factors
    Joyner, Michael J., Green, Daniel J. · 2009 · The Journal of Physiology
54. Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association
    Goldstein, Benjamin I., Carnethon, Mercedes R., Matthews, Karen A., McIntyre, Roger S., Miller, Gregory E., Raghuveer, Geetha, Stoney, Catherine M., Wasiak, Hank, McCrindle, Brian W. · 2015 · Circulation
55. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
    Handelsman, Yehuda, Mechanick, Jeffrey I., Blonde, Lawrence, Grunberger, George, Bloomgarden, Zachary T., Bray, George A., Dagogo-Jack, Samuel, Davidson, Jaime A., Einhorn, Daniel, Ganda, Om et al. · 2011 · Endocrine Practice
56. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
    Wilbert S. Aronow, Jerome L. Fleg, Carl J. Pepine, Nancy T. Artinian, George L. Bakris, Alan S. Brown, Keith C. Ferdinand, Mary Ann Forciea, William H. Frishman, Cheryl S. Jaigobin et al. · 2011 · Journal of the American College of Cardiology
57. Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
    Steven Kyle Grinspoon, Kathleen V. Fitch, Markella V. Zanni, Carl J. Fichtenbaum, Triin Umbleja, Judith A. Aberg, Edgar Turner Overton, Carlos Malvestutto, Gerald S. Bloomfield, Judith S. Currier et al. · 2023 · New England Journal of Medicine
58. Serum amyloid A – a review
    George H. Sack · 2018 · Molecular Medicine
59. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
    Blonde, Lawrence, Umpierrez, Guillermo E., Reddy, S. Sethu, McGill, Janet B., Berga, Sarah L., Bush, Michael, Chandrasekaran, Suchitra, DeFronzo, Ralph A., Einhorn, Daniel, Galindo, Rodolfo J. et al. · 2022 · Endocrine Practice
60. Effect of statins on skeletal muscle function
    Parker, Beth A., Capizzi, Jeffrey A., Grimaldi, Adam S., Clarkson, Priscilla M., Cole, Stephanie M., Keadle, Justin, Chipkin, Stuart, Pescatello, Linda S., Simpson, Kathleen, White, C. Michael et al. · 2013 · Circulation
61. High-Sensitivity C-Reactive Protein and Cardiovascular Disease
    Omair Khwaja Yousuf, Bibhu D. Mohanty, Seth Shay Martin, Parag H. Joshi, Michael Joseph Blaha, Khurram Nasir, Roger Scott Blumenthal, Matthew Jay Budoff · 2013 · Journal of the American College of Cardiology
62. Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection
    Amanda N. Long, Samuel E. Dagogo-Jack · 2011 · Journal of Clinical Hypertension
63. Inflammation and type 2 diabetes
    Mariana C. Calle, María Luz Fernández · 2012 · Diabetes & Metabolism
64. Visceral Obesity
    Patrick Mathieu, Paul Poirier, Philippe Pîbarot, Isabelle Lemieux, Jean‐Pierre Després · 2009 · Hypertension
65. An assessment by the statin muscle safety task force: 2014 update
    Rosenson, Robert S., Baker, Steven K., Jacobson, Terry A., Kopecky, Stephen L., Parker, Beth A. · 2014 · Journal of Clinical Lipidology
66. Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)
    Blaha, Michael J., Cainzos-Achirica, Miguel, Greenland, Philip, McEvoy, John W., Blankstein, Ron, Budoff, Matthew J., Dardari, Zeina, Sibley, Christopher T., Burke, Gregory L., Kronmal, Richard A. et al. · 2016 · Circulation
67. Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
    Heriberto Rodríguez-Hernández, Luis E. Simental‐Mendía, Gabriela Rodríguez Ramírez, Miguel Arturo Reyes-Romero · 2013 · International Journal of Endocrinology
68. Inflammatory processes in cardiovascular disease: a route to targeted therapies
    Ruparelia, Neil, Chai, Joshua T., Fisher, Edward A., Choudhury, Robin P. · 2017 · Nature Reviews Cardiology
69. Prevalence of statin intolerance: a meta-analysis
    Bytyçi, Ibadete, Penson, Peter E, Mikhailidis, Dimitri P, Wong, Nathan D, Hernandez, Adrian V, Sahebkar, Amirhossein, Thompson, Paul D, Mazidi, Mohsen, Rysz, Jacek, Pella, Daniel et al. · 2022 · European Heart Journal
70. Statins: new American guidelines for prevention of cardiovascular disease
    Paul M. Ridker, Nancy R. Cook · 2013 · The Lancet
71. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
    Josef S Smolen, Daniel Aletaha · 2015 · Nature Reviews Rheumatology
72. Inflammation and cardiovascular disease: From mechanisms to therapeutics
    Alfaddagh, Abdulhamied, Martin, Seth S., Leucker, Thorsten M., Michos, Erin D., Blaha, Michael J., Lowenstein, Charles J., Jones, Steven R., Toth, Peter P. · 2020 · American Journal of Preventive Cardiology
73. 2016 Chinese guidelines for the management of dyslipidemia in adults.
    2018 · Europe PMC (PubMed Central)
74. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary
    Terry A. Jacobson, Matthew K. Ito, Kevin Carl Maki, Carl E. Orringer, Harold Edward Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward Allen Gill, Robert A. Wild et al. · 2014 · Journal of clinical lipidology
75. Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
    Khera, Amit V., Everett, Brendan M., Caulfield, Michael P., Hantash, Feras M., Wohlgemuth, Jay, Ridker, Paul M, Mora, Samia · 2014 · Circulation
76. Inflammatory cytokines in atherosclerosis: current therapeutic approaches
    Dimitris Tousoulis, Evangelos K. Oikonomou, Evangelos K. Economou, Filippo Crea, Juan Carlos Kaski · 2016 · European Heart Journal
77. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    Lloyd-Jones, Donald M., Morris, Pamela B., Ballantyne, Christie M., Birtcher, Kim K., Daly, David D., DePalma, Sondra M., Minissian, Margo B., Orringer, Carl E., Smith, Sidney C. · 2016 · Journal of the American College of Cardiology
78. Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
    Parhofer, Klaus G. · 2015 · Diabetes &amp; Metabolism Journal
79. Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
    Patrizia Gazzerro, Maria Proto, Giuseppina Gangemi, Anna Maria Malfitano, Elena Ciaglia, Simona Pisanti, Antonietta Santoro, Chiara Laezza, Maurizio Bifulco · 2011 · Pharmacological Reviews
80. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
    Nathalie Conrad, Geert N. Verbeke, Geert Molenberghs, Laura Goetschalckx, Thomas Callender, Geraldine Cambridge, Justin Charles Mason, Kazem Rahimi, John J.V. McMurray, Jan Yvan Jos Verbakel · 2022 · The Lancet
81. Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants
    Ray, Kausik K. · 2010 · Archives of Internal Medicine
82. Targeting cardiovascular inflammation: next steps in clinical translation
    Patrick R. Lawler, Deepak L. Bhatt, Lucas C. Godoy, Thomas Felix Lüscher, Robert O. Bonow, Subodh Verma, Paul M. Ridker · 2020 · European Heart Journal
83. Protective effects of sirtuins in cardiovascular diseases: from bench to bedside
    Stephan H. Winnik, Johan H. Auwerx, David A. Sinclair, Christian M. Matter · 2015 · European Heart Journal
84. Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
    Sampson, Uchechukwu K., Fazio, Sergio, Linton, MacRae F. · 2012 · Current Atherosclerosis Reports
85. Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
    Rajpathak, Swapnil N., Kumbhani, Dharam J., Crandall, Jill, Barzilai, Nir, Alderman, Michael, Ridker, Paul M. · 2009 · Diabetes Care
86. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
    Paolo Raggi, Jacques J. Genest, Jon T. Giles, Katey J. Rayner, Girish Dwivedi, Rob S. Beanlands, Milan Gupta · 2018 · Atherosclerosis
87. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
    Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Leite Simão, Óscar Pereira Dutra, Otávio Rizzi Coelho-Filho, Maria Cristina de Oliveira Izar, Rui Póvoa, Isabela de Carlos Back Giuliano, Aristóteles Comte de Alencar Filho, Carlos Alberto Machado et al. · 2019 · Arquivos Brasileiros de Cardiologia
88. ST-segment elevation myocardial infarction
    Birgit Vogel, Bimmer E.P.M. Claessen, Suzanne V. Arnold, Danny Chan, David J. Cohen, Evangelos Giannitsis, Charles Michael Gibson, Shinya Goto, Hugo Albert Katus, Mathieu Kernéis et al. · 2019 · Nature Reviews Disease Primers
89. Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis
    Michael A. Gimbrone, Guillermo García‐Cardeña · 2012 · Cardiovascular Pathology
90. Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
    Alexios S. Antonopoulos, Marios Margaritis, Regent Lee, Keith M. Channon, Charalambos A. Antoniades · 2012 · Current Pharmaceutical Design
91. Adiposopathy
    Bays, Harold E. · 2011 · Journal of the American College of Cardiology
92. 2013 ESH/ESC Guidelines for the management of arterial hypertension
    Giuseppe Mancia, Robert H. Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry CM Christiaens, Renata Cífková, Guy De Backer, Anna F. Dominiczak et al. · 2013 · Blood Pressure
93. Safety and efficacy of statin therapy
    Adhyaru, Bhavin B., Jacobson, Terry A. · 2018 · Nature Reviews Cardiology
94. Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
    Symen Ligthart, Ahmad Vaez, Urmo Võsa, Maria G. Stathopoulou, Paul S. de Vries, Bram P. Prins, Peter J. van der Most, Toshiko Tanaka, Elnaz Naderi, Lynda M. Rose et al. · 2018 · The American Journal of Human Genetics
95. Vascular Complications of Diabetes
    Joshua A. Beckman, Mark A. Creager · 2016 · Circulation Research
96. A Test in Context
    Ridker, Paul M · 2016 · Journal of the American College of Cardiology
97. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
    Josefin Soppert, Michael Lehrke, Nikolaus Marx, Joachim Jankowski, Heidi Noels · 2020 · Advanced Drug Delivery Reviews
98. Risk of incident diabetes among patients treated with statins: population based study
    Carter, A. A., Gomes, T., Camacho, X., Juurlink, D. N., Shah, B. R., Mamdani, M. M. · 2013 · BMJ
99. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models
    Robert Kleemann, Lars Verschuren, Martine C. Morrison, Susanne Zadelaar, Marjan J. van Erk, Peter Y. Wielinga, Teake Kooistra · 2011 · Atherosclerosis
100. Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
     Krista L. Lentine, Salvatore P. Costa, Matthew R. Weir, John F. Robb, Lee A. Fleisher, B.L. Kasiske, Robert L. Carithers, Michael Ragosta, Kline Bolton, Andrew David Auerbach et al. · 2012 · Journal of the American College of Cardiology